Meta Pixel

News and Announcements

iFAST Singapore officially admitted as a Trading Member of SGX-ST

  • Published June 09, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

The Board of Directors of iFAST Corporation Ltd. is pleased to announce that the Company’s wholly-owned subsidiary, iFAST Financial Pte Ltd has been officially admitted as a Trading Member of Singapore Exchange Securities Trading Limited and a Clearing Member of The Central Depository Limited with effect from 9 June 2017.

The admission will allow iFAST Singapore to launch its stock dealing service in SGX-listed stocks over the next few weeks.

Request Information 

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now